HLA-DR4Pred2: an improved method for predicting HLA-DRB1*04:01 binders
暂无分享,去创建一个
[1] P. Agrawal,et al. Pfeature: A Tool for Computing Wide Range of Protein Features and Building Prediction Models , 2022, J. Comput. Biol..
[2] G. Solgi,et al. HLA-DRB1*04 may predict the severity of disease in a group of Iranian COVID-19 patients , 2021, Human Immunology.
[3] B. Lie,et al. The influence of HLA genotype on the severity of COVID‐19 infection , 2021, HLA.
[4] A. Hosseini,et al. HLA, Immune Response, and Susceptibility to COVID-19 , 2021, Frontiers in Immunology.
[5] S. El-Kafrawy,et al. Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants , 2020, International Journal of Infectious Diseases.
[6] S. Rowland-Jones,et al. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus , 2020, Cell.
[7] L. García,et al. Immune Response, Inflammation, and the Clinical Spectrum of COVID-19 , 2020, Frontiers in Immunology.
[8] E. Elinav,et al. Interaction between microbiota and immunity in health and disease , 2020, Cell Research.
[9] A. Vogrig,et al. Associations between HLA and autoimmune neurological diseases with autoantibodies , 2020, Autoimmunity Highlights.
[10] Paul Flicek,et al. IPD-IMGT/HLA Database , 2019, Nucleic Acids Res..
[11] Hari Prasad Devkota,et al. Polyphenols in the treatment of autoimmune diseases. , 2019, Autoimmunity reviews.
[12] J. L. Sánchez-Trincado,et al. Fundamentals and Methods for T- and B-Cell Epitope Prediction , 2017, Journal of immunology research.
[13] Wei Jiang,et al. The Other Function: Class II-Restricted Antigen Presentation by B Cells , 2017, Front. Immunol..
[14] Frank Noé,et al. Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation , 2017, Front. Immunol..
[15] K. Rock,et al. Present Yourself! By MHC Class I and MHC Class II Molecules. , 2016, Trends in immunology.
[16] Y. Mosaad,et al. Clinical Role of Human Leukocyte Antigen in Health and Disease , 2015, Scandinavian journal of immunology.
[17] H. Chen,et al. Association of HLA-DR4/HLA-DRB1*04 with Vogt-Koyanagi-Harada disease: A Systematic Review and Meta-analysis , 2014, Scientific Reports.
[18] M. Claesson,et al. Classification of Human Leukocyte Antigen (HLA) Supertypes , 2014, Methods in molecular biology.
[19] F. Dammacco,et al. MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells. , 2013, Journal of the National Cancer Institute.
[20] D. Cole,et al. Re-Directing CD4+ T Cell Responses with the Flanking Residues of MHC Class II-Bound Peptides: The Core is Not Enough , 2013, Front. Immunol..
[21] I. Lucenko,et al. Associations of HLA DR and DQ molecules with Lyme borreliosis in Latvian patients , 2012, BMC Research Notes.
[22] Celine Vens,et al. Identifying discriminative classification-based motifs in biological sequences , 2011, Bioinform..
[23] Morten Nielsen,et al. Major histocompatibility complex class I binding predictions as a tool in epitope discovery , 2010, Immunology.
[24] Morten Nielsen,et al. MHC Class II epitope predictive algorithms , 2010, Immunology.
[25] David Burgner,et al. HLA and Infectious Diseases , 2009, Clinical Microbiology Reviews.
[26] Morten Nielsen,et al. Quantitative Predictions of Peptide Binding to Any HLA-DR Molecule of Known Sequence: NetMHCIIpan , 2008, PLoS Comput. Biol..
[27] Morten Nielsen,et al. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method , 2007, BMC Bioinformatics.
[28] S. Choo. The HLA System: Genetics, Immunology, Clinical Testing, and Clinical Implications , 2007, Yonsei medical journal.
[29] W. L. Benedict,et al. Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.
[30] K. Gillespie. Type 1 diabetes: pathogenesis and prevention , 2006, Canadian Medical Association Journal.
[31] Jianming Shi,et al. Prediction of MHC class II binders using the ant colony search strategy , 2005, Artif. Intell. Medicine.
[32] S. Hauser,et al. The HLA locus and multiple sclerosis in Sicily , 2005, Neurology.
[33] C. Larsen,et al. The genetics of HLA-associated disease. , 2004, Current opinion in immunology.
[34] Thomas L. Madden,et al. BLAST: at the core of a powerful and diverse set of sequence analysis tools , 2004, Nucleic Acids Res..
[35] G. Crooks,et al. WebLogo: a sequence logo generator. , 2004, Genome research.
[36] JL Newton,et al. A review of the MHC genetics of rheumatoid arthritis , 2004, Genes and Immunity.
[37] Gajendra P. S. Raghava,et al. SVM based method for predicting HLA-DRB1*0401 binding peptides in an antigen sequence , 2004, Bioinform..
[38] J. Taurog. HLA-DR4 and the spondyloarthropathies , 2002, Annals of the rheumatic diseases.
[39] Gajendra P. S. Raghava,et al. ProPred: prediction of HLA-DR binding sites , 2001, Bioinform..
[40] T. Pincus,et al. HLA-DR4 and other genetic markers in rheumatoid arthritis. , 1988, British journal of rheumatology.
[41] Rolf Apweiler,et al. The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000 , 2000, Nucleic Acids Res..
[42] G. Dunston,et al. Vitiligo is associated with HLA-DR4 in black patients. A preliminary report. , 1990, Archives of dermatology.